Please Enable JavaScript

www.laserfocusworld.comis using a security service for protection against online attacks.
The service requires full JavaScript support in order to view this website.

Please enable JavaScript on your browser and try again.

www.laserfocusworld.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

COVID-variant booster from Sanofi, GSK shows promising results

By: MarketWatch

June 13, 2022 at 17:13 PM EDT

A COVID-19 vaccine developed by Sanofi SA and GSK PLC to target the Beta strain of the virus produced a stronger antibody response against variants of omicron when given as a booster compared with certain first-generation shots, two studies have found.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Please Enable Cookies

COVID-variant booster from Sanofi, GSK shows promising results